Patent details

EP2213725 Title: Animal protein-free media for cultivation of cells

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2213725
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10004393.4
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
12/10/2005
Grant date:
22/08/2012
EP Publication Date:
04/08/2010
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
29/02/2024
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
22/08/2012
EP B1 Publication Date:
22/08/2012
EP B2 Publication Date:
14/02/2024
EP B3 Publication Date:
Description Translation B1 Received Date:
20/09/2012
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
11/10/2025
Lapsed By Expiration Date:
12/10/2025
Patent Validated Date:
05/03/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
17/06/2021
 
 

 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, Japan (JP)

Historical Applicant/holder

From:
05/04/2016
To:
17/06/2021

 

Name:
Baxalta Incorporated
Address:
1200 Lakeside Drive, 60015, Bannockburn, Illinois, United States of America (US)

From:
05/04/2016
To:
17/06/2021

 

Name:
Baxalta GmbH
Address:
Thurgauerstrasse 130, 8152, Glattpark, (Opfikon), Switzerland (CH)

From:
22/08/2012
To:
05/04/2016

 

Name:
Baxter International Inc.
Address:
One Baxter Parkway, DEERFIELD, IL 60015, United States of America (US)

From:
22/08/2012
To:
05/04/2016

 

Name:
Baxter Healthcare S.A.
Address:
Thurgauerstrasse 130, 8152 GLATTPARK (OPFIKON), Switzerland (CH)

Agent

Name:
ir. A. Blokland c.s.
From:
01/03/2024
Address:
Algemeen Octrooi- en Merkenbureau B.V. Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
To:

Domicile Holder

Name:
ir. A. Blokland c.s.
From:
22/08/2012
Address:
Algemeen Octrooi- en Merkenbureau B.V. Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
To:
01/03/2024

Inventor

1

Name:
Grillberger, Leopold
Address:
1220 Vienna, Austria (AT)

2

Name:
Reiter, Manfred
Address:
1150 Vienna, Austria (AT)

3

Name:
Mundt, Wolfgang
Address:
1080 Vienna, Austria (AT)

4

Name:
Dorner, Friedrich
Address:
1230 Vienna, Austria (AT)

Priority

Priority Patent Number:
976399
Priority Date:
29/10/2004
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C12N 5/02; C12N 7/02; C12N 1/16; C12N 1/20;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
42/25
Publication date:
15/10/2025
Description:
Lapse or annulment

2

Bulletin Heading:
EP5
Journal edition number:
10/24
Publication date:
06/03/2024
Description:
European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995

3

Bulletin Heading:
EP4
Journal edition number:
07/24
Publication date:
14/02/2024
Description:
European patents granted in amended form for the Netherlands

4

Bulletin Heading:
MED
Journal edition number:
07/24
Publication date:
14/02/2024
Description:
Other communications

5

Bulletin Heading:
CO
Journal edition number:
27/21
Publication date:
07/07/2021
Description:
Changes in the Netherlands Patent Register

6

Bulletin Heading:
CO
Journal edition number:
22/16
Publication date:
01/06/2016
Description:
Changes in the Netherlands Patent Register

7

Bulletin Heading:
VB1
Journal edition number:
2013/27
Publication date:
03/07/2013
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

8

Bulletin Heading:
EP3
Journal edition number:
2012/43
Publication date:
24/10/2012
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

9

Bulletin Heading:
EP2
Journal edition number:
2012/35
Publication date:
29/08/2012
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202407
Publication date:
14/02/2024
Description:
Patent maintained (B2 publication)

2

Issue number:
201523
Publication date:
03/06/2015
Description:
Title of invention Modified

3

Issue number:
201326
Publication date:
26/06/2013
Description:
Opposition procedure started

4

Issue number:
201234
Publication date:
22/08/2012
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202101203A
Date Registered:
17/06/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Baker & McKenzie Amsterdam N.V.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, Japan (JP)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201600876B
Date Registered:
05/04/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Baker & Mc.Kenzie Amsterdam N.V.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Baxalta Incorporated
Address:
1200 Lakeside Drive, 60015, Bannockburn, Illinois, United States of America (US)

2

Name:
Baxalta GmbH
Address:
Thurgauerstrasse 130, 8152, Glattpark, (Opfikon), Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
19/09/2024
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
04/03/2024 Outgoing Correspondence Letter no formal defects 1 PDF /3/9/3/4/0/0510004393/docs/ep10004393.4_5_594934l271.pdf
29/02/2024 Claims First filed claims 2 PDF /3/9/3/4/0/0510004393/docs/ep10004393.4_9_claims20240229104519950.pdf
25/05/2016 Outgoing Correspondence Outgoing Letter 1 PDF /3/9/3/4/0/0510004393/docs/ep10004393.4_1_58322l118.pdf
05/04/2016 Request for Change Subsequently filed deed 18 PDF /3/9/3/4/0/0510004393/docs/ep10004393.4_0_rfc20160525021031294.pdf
05/04/2016 Incoming Correspondence Paper Other 357 PDF /3/9/3/4/0/0510004393/docs/ep10004393.4_3_incomingcorrespondencepaper20160525021031381.pdf
05/04/2016 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /3/9/3/4/0/0510004393/docs/ep10004393.4_6_incomingcorrespondencepaper20160525021031155.pdf
05/04/2016 Incoming Correspondence Paper Other 306 PDF /3/9/3/4/0/0510004393/docs/ep10004393.4_7_incomingcorrespondencepaper20160601092948490.pdf
05/04/2016 Incoming Correspondence Paper Other 3 PDF /3/9/3/4/0/0510004393/docs/ep10004393.4_8_incomingcorrespondencepaper20160525021031239.pdf
20/09/2012 Claims Translated claims 2 PDF /3/9/3/4/0/0510004393/docs/ep10004393.4_4_claims20120920.pdf
29/08/2012 Incoming Correspondence Paper Correspondence address details 1 PDF /3/9/3/4/0/0510004393/docs/ep10004393.4_2_incomingcorrespondencepaper20120829.pdf